Loading clinical trials...
Loading clinical trials...
A Pivotal, Randomized, Placebo-controlled, Double-blind, Multicenter, International Phase III Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-CVU on Wound Healing of Therapy-Resistant Non-Healing Chronic Venous Ulcers (CVU)
Conditions
Interventions
allo-APZ2-CVU
Placebo
Locations
15
United States
RHEACELL Clinical Trial Site
Hialeah, Florida, United States
RHEACELL Clinical Trial Site
Miami, Florida, United States
RHEACELL Clinical Trial Site
Boston, Massachusetts, United States
RHEACELL Clinical Trial Site
Minneapolis, Minnesota, United States
RHEACELL Clinical Trial Site
Multiple Locations, Austria
RHEACELL Clinical Trial Site
Multiple Locations, Czechia
Start Date
December 26, 2024
Primary Completion Date
April 1, 2027
Completion Date
September 1, 2027
Last Updated
October 1, 2025
NCT07541196
NCT06811909
NCT05489588
NCT06754735
NCT07046767
NCT06606210
Lead Sponsor
RHEACELL GmbH & Co. KG
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions